Norfloxacin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01059 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 43 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hyperamylasemia | KG + DL |
| 2 | polyclonal hyperviscosity syndrome | KG + DL |
| 3 | congenital analbuminemia | KG + DL |
| 4 | blood group incompatibility | KG + DL |
| 5 | punctate epithelial keratoconjunctivitis | KG + DL |
| 6 | premalignant hematological system disease | KG + DL |
| 7 | diffuse scleroderma | KG + DL |
| 8 | monoclonal gammopathy | KG + DL |
| 9 | hematological disease associated with an acquired peripheral neuropathy | KG + DL |
| 10 | septicemic plague | KG + DL |
| 11 | congenital hematological disorder | KG + DL |
| 12 | exposure keratitis | KG + DL |
| 13 | postinfectious vasculitis | KG + DL |
| 14 | post-infectious syndrome | KG + DL |
| 15 | post-bacterial disorder | KG + DL |
| 16 | bubonic plague | KG + DL |
| 17 | infective urethral stricture | KG + DL |
| 18 | Chagas cardiomyopathy | KG + DL |
| 19 | infection-related hemolytic uremic syndrome | KG + DL |
| 20 | amebic dysentery | KG + DL |
| 21 | non-human animal disease | KG + DL |
| 22 | chronic rhinosinusitis | KG + DL |
| 23 | eosinophilia-myalgia syndrome | KG + DL |
| 24 | L-ferritin deficiency | KG + DL |
| 25 | chronic ethmoidal sinusitis | KG + DL |
| 26 | sinusitis | KG + DL |
| 27 | paranasal sinus neoplasm (disease) | KG + DL |
| 28 | chronic gingivitis | KG + DL |
| 29 | infectious otitis interna | KG + DL |
| 30 | hematopoietic and lymphoid system neoplasm | KG + DL |
| 31 | staphylococcal toxemia | KG + DL |
| 32 | splenic disease | KG + DL |
| 33 | pneumonia of swine, mycoplasmal | KG + DL |
| 34 | pneumonic plague | KG + DL |
| 35 | pyelitis | KG + DL |
| 36 | lymphoid system disease | KG + DL |
| 37 | epidemic keratoconjunctivitis | KG + DL |
| 38 | neurotrophic keratopathy | KG + DL |
| 39 | gingivitis | KG + DL |
| 40 | gingival disease | KG + DL |
| 41 | hordeolum externum | KG + DL |
| 42 | pericoronitis | KG + DL |
| 43 | bacterial sexually transmitted disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.